SI-BONE (SIBN) shares preliminary 2025 figures and investor presentation

Rhea-AI Filing Summary

SI-BONE, Inc. filed a current report describing that it has released a press release with preliminary unaudited revenue and cash and equivalents figures for the fourth quarter and full year 2025. These early numbers are meant to give the market an initial view of the company’s recent performance and year-end liquidity before audited results are available.

The company also plans meetings with investors and analysts, supported by a slide presentation. Both the press release and the presentation are included as exhibits and are being furnished, not filed, which means they are not automatically incorporated into other securities law filings.

0001459839false00014598392026-01-122026-01-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________________________________________________________

FORM 8-K

____________________________________________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 12, 2026

____________________________________________________________________________

SI-BONE, INC.

(Exact name of registrant as specified in its charter)

____________________________________________________________________________

Delaware

001-38701

26-2216351

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

471 El Camino Real

Suite 101

Santa Clara, CA 95050

(Address of principal executive offices) (Zip Code)

(408) 207-0700

(Registrant’s telephone number, include area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.0001 per share			SIBN			The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On January 12, 2026, SI-BONE, Inc. (the "Company") issued a press release (the “Press Release”) announcing preliminary unaudited revenue and cash and equivalents for the fourth quarter and full year 2025. A copy of the Press Release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.

Item 7.01 Regulation FD Disclosure.

Members of the Company's management team expect to meet with investors and analysts the week of January 12, 2026, to discuss the Company performance, using presentation materials which are furnished and attached as Exhibit 99.2.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.						Description
99.1						Press release dated January 12, 2026
99.2						Presentation dated January 12, 2026
104						Cover Page Interactive Date File (embedded within the Inline XBRL document)

The information in Items 2.02 and 7.01 and Exhibits 99.1 and 99.2, of this Current Report on Form 8-K are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 as amended (Exchange Act), or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (Securities Act). The information in Items 2.02 and 7.01, and Exhibits 99.1 and 99.2 shall not be deemed incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						SI-BONE, INC.
Date:			January 12, 2026			By:			/s/ Anshul Maheshwari
									Anshul Maheshwari
									Chief Financial Officer
									(Principal Financial and Accounting Officer)

FAQ

What did SI-BONE, Inc. (SIBN) disclose in this 8-K?

SI-BONE, Inc. disclosed that it issued a press release containing preliminary unaudited revenue and cash and equivalents for the fourth quarter and full year 2025, and it attached that press release as an exhibit.

Does the 8-K for SI-BONE (SIBN) include detailed financial results?

The 8-K states that preliminary unaudited revenue and cash and equivalents for the fourth quarter and full year 2025 are provided in an attached press release, but the specific figures are contained in that exhibit rather than in the main body of the report.

How is the information about SI-BONE’s preliminary 2025 results treated legally?

The company states that the information in Items 2.02 and 7.01 and Exhibits 99.1 and 99.2 is being furnished and not filed, so it is not subject to certain liabilities of the Exchange Act and is not automatically incorporated into other Securities Act or Exchange Act filings.

What exhibits are attached to the SI-BONE (SIBN) 8-K?

The report attaches a press release dated January 12, 2026 as Exhibit 99.1, a presentation dated the same day as Exhibit 99.2, and a cover page interactive data file as Exhibit 104.

Will SI-BONE’s management discuss these preliminary results with investors?

Yes. The filing states that members of SI-BONE’s management team expect to meet with investors and analysts to discuss company performance, using the presentation attached as Exhibit 99.2.

Are SI-BONE’s preliminary 2025 numbers audited?

No. The filing specifies that the revenue and cash and equivalents figures for the fourth quarter and full year 2025 are preliminary and unaudited.